Skip to content

Wallis Interspinous Dynamic Stability System for Lumbar Disc Herniation: a Prospective Study

Effectiveness of Wallis Interspinous Dynamic Stability System for Lumbar Disc Herniation: a Prospective Randomised Controlled Study

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01824108
Enrollment
80
Registered
2013-04-04
Start date
2008-07-31
Completion date
2012-10-31
Last updated
2013-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation

Keywords

Lumbar disc herniation, Wallis interspinous implants, lumbar discectomy, interspinous dynamic stability system

Brief summary

Lumbar disc herniation is usually treated by discectomy alone. Nonfusion system such as Wallis interspinous implants have also been successfully used in disc degenerative diseases. However, the superiority of a discectomy with Wallis in comparison to a discectomy alone for primary lumbar disc herniation has yet to be determined.The aim of our study is to investigate whether lumbar discectomy combined with the Wallis device provides better radiographic and clinical short-term outcome than posterior lumbar discectomy alone.

Detailed description

The most commonly used therapy for lumbar disc herniation (LDH) are partial discectomy or discectomy with fusion if there was an additional mechanical disorder in the underlying functional spinal unit. However, the problems associated with discectomy are intervertebral disc height loss and the segmental instability, thought to be a risk for failed back surgery syndrome or recurrence lumbar disc herniation. Fusion has also been criticised for its side effects of adjacent segment degeneration(ASD), pseudarthrosis and bone-graft morbidity. To prevent such complications , a new family of dynamic implants have been established. Wallis interspinous implant (Abbott Laboratories, Bordeaux, France) , invented by J. Senegas, is one of them. It consisted of a interspinous blocker made out of polyetheretherketone (PEEK) to limit extension and two dacron tapes around the spinous processes in order to secure the implant and limit flexion. The aim of using this device is to unload the facet joints, to restore foraminal height and to provide sufficient stability especially in extension but still allow motion in the treated segment. Previous clinical trials and biomechanical studies are promising, however, the superiority of a discectomy with Wallis in comparison to a discectomy alone for primary lumbar disc herniation has yet to be determined. The purpose of this prospective controlled study was to evaluate the clinical effect of lumbar discectomy combined with Wallis interspinous device, comparing with posterior lumbar discectomy alone. Our hypothesis was that the use of the Wallis device would have better clinical and radiological outcomes than lumbar discectomy alone.

Interventions

All the patients were in prone positions on the operation table and received general anesthesia. A midline incision was made and paravertebral muscles were dissected unilaterally. Disc excision and nerve root decompression were initially accomplished through a unilateral transflaval approach. Then the wound was closed with a suction drain.

PROCEDURELumbar discectomy combined with Wallis interspinous dynamic stability system

The Wallis interspinous implant is placed after a lumbar discectomy. Interspinal ligaments of operated segment were removed and supraspinal ligament were retained. And then the proper size of Wallis implant was mounted underneath the supraspinous ligament and secured to the spine with the attached Dacron bands,above and below the corresponding spinous processes.

Sponsors

Guangdong Provincial People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. 18-70 years old; 2. complaining low back pain or radioactive melosalgia; 3. preoperative image examination showing disc herniation or spinal stenosis caused by herniation of responsible level; 4. no improvement in symptoms after 6-10 weeks of non-surgical treatment.

Exclusion criteria

1. previous operations; 2. congenital spinal deformity; 3. lumbar fracture; 4. infection; 5. autoimmune diseases; 6. serious osteoporosis; 7. morbidly obese;

Design outcomes

Primary

MeasureTime frameDescription
Oswestry Disability Index (ODI) at 24 months after intervention24 months after intervention
Oswestry Disability Index (ODI) at 2 days before intervention2 days before interventionbaseline ODI
Oswestry Disability Index (ODI) at 1 week after intervention1 week after intervention
Oswestry Disability Index (ODI) at 12 months after intervention12 months after intervention
Visual Analogue Scale (VAS) at 2 days before intervention2 days before interventionbaseline VAS
Visual Analogue Scale (VAS) at 1 week after intervention1 week after intervention
Visual Analogue Scale (VAS) at 12 months after intervention12 months after intervention
Visual Analogue Scale (VAS) at 24 months after intervention24 months after intervention
Japanese Orthopedics Association (JOA) at 2 days before intervention2 days before interventionbaseline JOA
Japanese Orthopedics Association (JOA) at 1 week after intervention1 week after intervention
Japanese Orthopedics Association (JOA) at 12 months after intervention12 months after intervention
Japanese Orthopedics Association (JOA) at 24 months after intervention24 months after intervention

Secondary

MeasureTime frameDescription
Range of motion of the operated segments2 days before intervention, 12 months and 24 months after intervention
Complications1 week, 12 months and 24 months after interventionComplications: includes dural laceration, implant loose, lumbar kyphosis, spinous process fracture or recurrent lumbar disc herniation
Intervertebral disc height of the operated segments2 days before intervention and 1 week, 12 months and 24 months after intervention

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026